Sinopharm Group Co. Ltd.
SHTDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $48,197,099 | $56,577,589 | $61,238,599 | $57,957,000 |
| - Cash | $35,238,139 | $54,313,359 | $43,331,766 | $63,808,538 |
| + Debt | $94,901,729 | $76,386,134 | $101,055,224 | $73,781,852 |
| Enterprise Value | $107,860,689 | $78,650,364 | $118,962,057 | $67,930,314 |
| Revenue | $286,042,998 | $289,781,120 | $294,726,810 | $295,619,285 |
| % Growth | -1.3% | -1.7% | -0.3% | – |
| Gross Profit | $20,775,431 | $22,312,095 | $21,943,295 | $25,240,997 |
| % Margin | 7.3% | 7.7% | 7.4% | 8.5% |
| EBITDA | $9,934,208 | $10,647,547 | $9,527,394 | $13,496,089 |
| % Margin | 3.5% | 3.7% | 3.2% | 4.6% |
| Net Income | $3,457,714 | $3,345,808 | $3,703,875 | $4,949,321 |
| % Margin | 1.2% | 1.2% | 1.3% | 1.7% |
| EPS Diluted | 1.11 | 1.07 | 1.19 | 1.59 |
| % Growth | 3.7% | -10.1% | -25.2% | – |
| Operating Cash Flow | -$34,111,089 | $52,539,678 | -$40,993,668 | $60,499,454 |
| Capital Expenditures | -$670,699 | -$1,437,558 | -$1,023,132 | -$1,240,196 |
| Free Cash Flow | -$34,781,788 | $51,102,120 | -$42,016,800 | $59,259,258 |